Purified anti-CTCF Antibody, CTCF, W19193A,BioLegend,942502

This clone was tested for ICC on HeLa cells fixed with 4% PFA and permeabilized with either methanol or Triton X-100. Both methods resulted in high cytosolic background staining.

Host

Rat

Reactivity

Human

Application

WB - Quality tested

Platform ID

BAB458414322

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePurified anti-CTCF Antibody, CTCF, W19193A
Cat. No.942502
HostRat
RRIDAB_2888905 (BioLegend Cat. No. 942501)AB_2888905 (BioLegend Cat. No. 942502)
IsotypeRat IgG2a, κ
ReactivityHuman
ApplicationWB - Quality tested
ClonalityMonoclonal
Clone NumberW19193A
Concentration0.5 mg/mL
TargetCTCF
ImmunogenSynthetic human CTCF peptide
PurityThe antibody was purified by affinity chromatography.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.
Regulatory StatusResearch Use Only

Scientific Background

CTCF is an 83 kD transcription factor found in the nucleoplasm, which translocates to the nucleolus when the cell is undergoing cell differentiation. This protein can act as an insulator protein by binding to an unmethylated imprinting control region (ICR) structure and prevent the activation of cis-acting elements which in turn prevents gene activation. CTCF becomes further involved in gene regulation when it forms a complex with cohesin. This complex can stabilize the formation of a chromatin loop, which can promote or repress the binding of other transcription factors to the promoter and enhancer, leading to gene activation or gene repression respectively. CTCF has a role as a tumor suppressor, when the gene goes through a mutation or deletion there is a rise in variance in CpG methylation throughout the genome. This methylation contributes to the development of aggressive and invasive tumors which are seen in breast, endometrial and bladder cancers.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.